---

---

symbols : GLAXF    crawled time : 12:00   

save search

---

CureVac veröffentlicht Finanzergebnisse für das dritte Quartal sowie die ersten neun Monate 2023 und informiert über seine Geschäftsentwicklung
Published: 2023-11-14 (Crawled : 12:00) - curevac.com
GLAXF | News | $20.2 -14.18% 510 |

Health Technology

| 17.24% | O: 1.57% H: 0.0% C: 0.0%
GSK | News | $39.75 1.22% 0.0% 1.6M |

Health Technology

| 14.42% | O: 0.12% H: 0.14% C: -0.49%
CVAC | $2.44 0.0% 790K |

Health Technology

| -55.72% | O: 3.45% H: 4.56% C: -0.7%

---

Centessa Pharmaceuticals Announces Additions to Senior Leadership Team
Published: 2023-10-03 (Crawled : 12:00) - globenewswire.com
CNTA | $10.555 0.24% 0.24% 150K |

Manufacturing

| 96.26% | O: 1.25% H: 1.93% C: -2.99%
GSK | News | $39.75 1.22% 0.0% 1.6M |

Health Technology

| 9.73% | O: 0.25% H: 0.08% C: -0.8%
pharmaceuticals

---

CureVac geht in Phase 2 der laufenden saisonalen Grippestudie in Zusammenarbeit mit GSK nach Auswahl eines vielversprechenden mRNA-Impfstoffkandidaten mit breiter Abdeckung
Published: 2023-09-12 (Crawled : 12:00) - curevac.com
GSK | News | $39.75 1.22% 0.0% 1.6M |

Health Technology

| 6.97% | O: -0.16% H: 0.09% C: -0.27%
CVAC | $2.44 0.0% 790K |

Health Technology

| -71.23% | O: -0.47% H: 0.62% C: -3.79%

---

Erasca Further Strengthens Business Leadership with Two Key Promotions
Published: 2023-05-16 (Crawled : 12:00) - globenewswire.com
GLAXF | News | $20.2 -14.18% 510 |

Health Technology

| 10.62% | O: -1.7% H: 3.06% C: 3.06%
ERAS | $1.79 0.0% 570K |

| -34.8% | O: -0.68% H: 0.68% C: -3.4%
GSK | News | $39.75 1.22% 0.0% 1.6M |

Health Technology

| 7.67% | O: -0.9% H: 0.6% C: 0.05%
business

---

Addiction therapeutics market size to increase by USD 9.86 billion between 2022 and 2027; Driven by high consumption of alcohol, tobacco, and opioid products - Technavio
Published: 2023-03-03 (Crawled : 12:00) - prnewswire.com
MNK | $0.3402 -0.06% 540K |

n/a

| -95.33% | O: 0.34% H: 4.11% C: 4.11%
GLAXF | News | $20.2 -14.18% 510 |

Health Technology

| 17.61% | O: 0.09% H: 1.57% C: 1.51%
VTRS A | $11.25 1.17% 1.16% 4.7M |

Health Technology

| -0.09% | O: 0.45% H: 0.45% C: -0.45%
GSK | News | $39.75 1.22% 0.0% 1.6M |

Health Technology

| 14.52% | O: -0.38% H: 0.65% C: 0.61%
opioid therapeutics market

---

Myelofibrosis Treatment Market to Reach $1.16 Billion, Globally, by 2031 at 4.0% CAGR: Allied Market Research
Published: 2023-02-06 (Crawled : 12:00) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510 |

Health Technology

| 16.16% | O: 2.88% H: 1.17% C: -2.24%
GSK | News | $39.75 1.22% 0.0% 1.6M |

Health Technology

| 13.7% | O: 1.64% H: 0.24% C: -0.17%
BMY | $48.93 1.3% 0.0% 10M |

Health Technology

| -35.12% | O: 0.0% H: 0.98% C: 0.11%
AMRX | $5.42 1.12% 1.11% 1.1M |

Health Technology

| 120.58% | O: 0.0% H: 6.58% C: 4.53%
ABBV | $166.41 1.06% 0.0% 5.5M |

Health Technology

| 13.75% | O: 0.37% H: 0.4% C: -0.49%
INCY | $52.3 -0.98% -0.99% 2.2M |

Health Technology

| -36.83% | O: 0.0% H: 1.47% C: 0.9%
GLTO | $0.72 4.71% 77K |

Health Technology

| -73.43% | O: -1.11% H: 3.36% C: 1.12%
treatment research market

---

Pulmonary Arterial Hypertension (PAH) Drugs Global Market 2022: Sector to Reach $9.4 Billion by 2027 at a CAGR of 5.29%
Published: 2023-02-03 (Crawled : 12:00) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510 |

Health Technology

| 16.9% | O: 0.12% H: 0.58% C: 0.52%
AZNCF | News | $138.24 -4.19% 800 |

Health Technology

| 6.47% | O: -0.63% H: 2.15% C: 1.68%
JNJ | News | $147.91 1.49% -0.03% 9.6M |

Health Technology

| -12.44% | O: 0.3% H: 0.19% C: -0.86%
GSK | News | $39.75 1.22% 0.0% 1.6M |

Health Technology

| 12.72% | O: 0.71% H: 0.42% C: -1.55%
UTHR | $237.99 0.45% 0.45% 400K |

Health Technology

| -9.31% | O: -0.1% H: 1.37% C: -2.48%
AZN | News | $68.56 0.29% 0.29% 4.7M |

Health Technology

| 8.1% | O: 0.79% H: 0.69% C: -0.33%
global hypertension market

---

CureVac begrüßt Dr. Myriam Mendila als neuen Chief Development Officer
Published: 2023-02-01 (Crawled : 12:00) - curevac.com
GLAXF | News | $20.2 -14.18% 510 |

Health Technology

| 16.63% | O: 1.91% H: 0.0% C: -1.42%
GSK | News | $39.75 1.22% 0.0% 1.6M |

Health Technology

| 12.31% | O: 0.0% H: 1.5% C: 0.65%
CVAC | $2.44 0.0% 790K |

Health Technology

| -77.28% | O: 0.74% H: 8.96% C: 8.96%
als

---

Global Antibiotics Market Report 2022 to 2027: Industry Trends, Share, Size, Growth, Opportunities and Forecasts
Published: 2023-01-23 (Crawled : 12:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K |

Health Technology

| -5.02% | O: 0.93% H: 0.0% C: 0.0%
JNJ | News | $147.91 1.49% -0.03% 9.6M |

Health Technology

| -14.1% | O: 0.21% H: 0.31% C: -0.47%
GSK | News | $39.75 1.22% 0.0% 1.6M |

Health Technology

| 11.93% | O: -0.06% H: 0.49% C: 0.0%
ABBV | $166.41 1.06% 0.0% 5.5M |

Health Technology

| 10.41% | O: 0.18% H: 0.38% C: -0.87%
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| -7.31% | O: -0.51% H: 0.0% C: 0.0%
NBRV | $1.42 1.39% 720K |

Health Technology

| -8.39% | O: 0.0% H: 1.29% C: -0.23%
antibiotics global report market

---

CureVac ernennt Alexander Zehnder zum Vorstandsvorsitzenden ab 1. April 2023
Published: 2023-01-09 (Crawled : 12:00) - curevac.com
GLAXF | News | $20.2 -14.18% 510 |

Health Technology

| 16.23% | O: 1.9% H: 0.0% C: -1.81%
SNYNF | News | $92.7 -2.18% 600K |

Health Technology

| -3.24% | O: 1.38% H: 0.28% C: 0.28%
GSK | News | $39.75 1.22% 0.0% 1.6M |

Health Technology

| 13.4% | O: 0.11% H: 0.69% C: -1.23%
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| -4.69% | O: 1.82% H: 0.0% C: 0.0%
CVAC | $2.44 0.0% 790K |

Health Technology

| -70.46% | O: 22.46% H: 10.13% C: 2.42%

---

Global Pulmonary Drug Delivery Systems Market Report to 2027 - Introduction of Smart Nebulizers Presents Opportunities
Published: 2023-01-03 (Crawled : 12:00) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510 |

Health Technology

| 15.53% | O: -0.2% H: 2.06% C: 2.06%
NVS | $94.36 1.93% 0.0% 2.3M |

Health Technology

| 2.6% | O: 0.42% H: 1.35% C: 1.22%
GSK | News | $39.75 1.22% 0.0% 1.6M |

Health Technology

| 12.69% | O: -0.57% H: 1.35% C: 1.0%
ABT | News | $107.28 1.91% 0.18% 10M |

Health Technology

| -3.09% | O: 0.66% H: 0.74% C: -0.84%
drug global report smart market

---

Cancer Gene Therapy Market To Reach a Valuation of USD 4047.8 Million by 2028 - Comprehensive Research Report by BrandEssence Market Research
Published: 2022-12-02 (Crawled : 12:00) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510 |

Health Technology

| 13.8% | O: 1.41% H: 0.0% C: -3.13%
AZNCF | News | $138.24 -4.19% 800 |

Health Technology

| -2.13% | O: -0.61% H: 0.08% C: -0.29%
NVS | $94.36 1.93% 0.0% 2.3M |

Health Technology

| 3.63% | O: -1.08% H: 1.44% C: 1.28%
GSK | News | $39.75 1.22% 0.0% 1.6M |

Health Technology

| 13.05% | O: -0.29% H: 1.55% C: 1.2%
CRNX | $42.98 -0.07% -0.07% 620K |

Health Technology

| 147.52% | O: -0.57% H: 5.9% C: 5.44%
AZN | News | $68.56 0.29% 0.29% 4.7M |

Health Technology

| -0.11% | O: -0.23% H: 0.79% C: 0.43%
ADAP | $0.97 7.97% 7.38% 1.5M |

Health Technology

| -49.01% | O: -0.99% H: 6.5% C: 3.0%
research report therapy cancer market

---

Global Immuno-oncology Market Report to 2028: An Increase in the Research and Development in Cancer Immunotherapy Will Be Driving Growth
Published: 2022-11-28 (Crawled : 12:00) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510 |

Health Technology

| 21.65% | O: 0.57% H: 0.0% C: -2.51%
AZNCF | News | $138.24 -4.19% 800 |

Health Technology

| 1.54% | O: -0.38% H: 1.09% C: 0.87%
NVSEF | $93.6375 6.88% 82K |

Health Technology

| 29.16% | O: 1.03% H: 0.0% C: -0.68%
NVS | $94.36 1.93% 0.0% 2.3M |

Health Technology

| 6.12% | O: 0.29% H: 0.45% C: -0.32%
GSK | News | $39.75 1.22% 0.0% 1.6M |

Health Technology

| 16.5% | O: -0.65% H: 0.83% C: -0.03%
LLY | News | $726.31 -2.63% -0.04% 3.5M |

Health Technology

| 105.55% | O: -0.49% H: 1.67% C: 0.64%
AZN | News | $68.56 0.29% 0.29% 4.7M |

Health Technology

| 3.17% | O: 0.12% H: 0.97% C: -0.06%
research global immunotherapy report cancer growth market

---

Parkinson's Disease Drugs Market to Reach $10.4 Bn, Globally, by 2031 at 6.2% CAGR: Allied Market Research
Published: 2022-11-17 (Crawled : 12:00) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510 |

Health Technology

| 24.31% | O: 0.98% H: 0.0% C: 0.0%
VTRS A | $11.25 1.17% 1.16% 4.7M |

Health Technology

| 0.36% | O: -1.62% H: 1.01% C: 0.55%
NVS | $94.36 1.93% 0.0% 2.3M |

Health Technology

| 11.41% | O: -1.56% H: 1.64% C: 1.47%
GSK | News | $39.75 1.22% 0.0% 1.6M |

Health Technology

| 20.33% | O: -2.04% H: 1.21% C: 1.09%
ABBV | $166.41 1.06% 0.0% 5.5M |

Health Technology

| 8.75% | O: -0.59% H: 1.39% C: 0.79%
BIIB | $194.39 2.03% 1.99% 1.6M |

Health Technology

| -34.95% | O: -0.98% H: 1.97% C: 1.68%
research disease parkinson's market

---

CureVac veröffentlicht Finanzergebnisse für das dritte Quartal sowie die ersten neun Monate 2022 und informiert über seine Geschäftsentwicklung
Published: 2022-11-16 (Crawled : 12:00) - curevac.com
GLAXF | News | $20.2 -14.18% 510 |

Health Technology

| 27.85% | O: 0.0% H: 2.85% C: 2.85%
GSK | News | $39.75 1.22% 0.0% 1.6M |

Health Technology

| 22.64% | O: 2.69% H: 0.27% C: -0.75%
CVAC | $2.44 0.0% 790K |

Health Technology

| -69.76% | O: -2.73% H: 5.99% C: 4.08%

---

Effervescent Tablet Market is Prospering at USD 15557.08 Million by 2029 Globally, Size, Share, Emerging Trends, Growth Factors, Demand and Competitive Outlook
Published: 2022-11-15 (Crawled : 12:00) - prnewswire.com
RBGPF | $51.61 6.46% 4.7K |

Consumer Non-Durables

| -20.68% | O: 2.6% H: 0.0% C: -1.02%
GLAXF | News | $20.2 -14.18% 510 |

Health Technology

| 29.24% | O: 5.12% H: 0.0% C: -3.83%
NVSEF | $93.6375 6.88% 82K |

Health Technology

| 34.88% | O: 0.4% H: 0.62% C: 0.59%
RBGLY | $10.35 -2.05% 990K |

Manufacturing

| -22.28% | O: 2.57% H: 0.44% C: 0.15%
PRGO | News | $30.8 2.87% -1.14% 1.2M |

Health Technology

| -7.97% | O: 0.89% H: 0.73% C: -0.52%
NVS | $94.36 1.93% 0.0% 2.3M |

Health Technology

| 11.54% | O: 0.77% H: 0.51% C: -0.31%
GSK | News | $39.75 1.22% 0.0% 1.6M |

Health Technology

| 21.7% | O: 0.31% H: 0.2% C: -1.07%
BMY | $48.93 1.3% 0.0% 10M |

Health Technology

| -36.77% | O: 0.03% H: 0.47% C: -0.17%
growth market

---

CureVac veröffentlicht vorläufige Daten der Phase 1-Erweiterungsstudie mit Onkologie-Kandidaten CV8102
Published: 2022-11-11 (Crawled : 12:00) - curevac.com
GLAXF | News | $20.2 -14.18% 510 |

Health Technology

| 29.99% | O: 2.8% H: 1.16% C: -2.72%
GSK | News | $39.75 1.22% 0.0% 1.6M |

Health Technology

| 18.31% | O: -4.96% H: 0.28% C: -0.72%
CVAC | $2.44 0.0% 790K |

Health Technology

| -66.85% | O: 2.72% H: 7.28% C: -2.78%
cv8102 phase 1

---

CureVac veröffentlicht am 16. November 2022 Finanzergebnisse des dritten Quartals sowie der ersten neun Monate 2022 und informiert über seine Geschäftsentwicklung
Published: 2022-11-10 (Crawled : 12:00) - curevac.com
GLAXF | News | $20.2 -14.18% 510 |

Health Technology

| 29.9% | O: -0.06% H: 0.0% C: 0.0%
GSK | News | $39.75 1.22% 0.0% 1.6M |

Health Technology

| 22.15% | O: 2.59% H: 0.72% C: 0.63%
CVAC | $2.44 0.0% 790K |

Health Technology

| -65.14% | O: 3.14% H: 2.63% C: 1.94%

---

Global Osteoporosis Drugs Market Report 2022: Anabolic Drug Developments Show High Potential to Reshape Sector
Published: 2022-11-07 (Crawled : 12:00) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510 |

Health Technology

| 25.0% | O: -3.13% H: 0.0% C: 0.0%
GSK | News | $39.75 1.22% 0.0% 1.6M |

Health Technology

| 20.04% | O: -3.09% H: 0.72% C: -0.09%
LLY | News | $726.31 -2.63% -0.04% 3.5M |

Health Technology

| 110.06% | O: 0.17% H: 2.51% C: 1.97%
AMGN | $269.03 2.39% 2.33% 3.4M |

Health Technology

| -1.53% | O: -0.33% H: 3.48% C: 3.31%
drug global report potential market osteoporosis

---

Pfizer Reports Strong Third-quarter 2022 Results and Raises 2022 Outlook
Published: 2022-11-01 (Crawled : 12:00) - biospace.com/
HLN | $8.22 1.11% 0.0% 3.6M |

n/a

| 32.52% | O: 0.16% H: 1.79% C: 0.16%
GLAXF | News | $20.2 -14.18% 510 |

Health Technology

| 20.89% | O: -1.68% H: 0.0% C: -0.27%
SNYNF | News | $92.7 -2.18% 600K |

Health Technology

| 12.16% | O: 7.74% H: 0.17% C: 0.17%
PFE A | $26.0 2.4% -0.15% 38M |

Health Technology

| -45.39% | O: 3.11% H: 0.88% C: 0.02%
GSK | News | $39.75 1.22% 0.0% 1.6M |

Health Technology

| 19.38% | O: 1.72% H: 0.39% C: -0.83%
BHVN 1 d | $38.99 -7.52% 0.0% 3.4M |

Health Technology

| 154.44% | O: 1.81% H: 3.08% C: -0.65%
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| 5.59% | O: 0.23% H: 0.0% C: 0.0%
BNTX | $86.82 0.75% 0.75% 1.6M |

Health Technology

| -37.39% | O: 4.54% H: 4.25% C: 0.13%
BEAM | $23.9 -1.69% -1.72% 4.5M |

Health Technology

| -41.67% | O: 3.25% H: 1.41% C: -2.48%
ARVN | $34.78 1.43% 1.41% 940K |

Health Technology

| -32.73% | O: 1.49% H: 3.25% C: 1.68%
results

---

Gainers vs Losers

67%

33%

Top 10 Gainers

AGBA | News | $1.26 215.0% 68.25% 130M |

Finance

EGOX | $0.0515 43.06% 30.1% 330M |

OLB 4 | $0.33 -14.95% 25.53% 840K |

Technology Services

NVFY | $2.77 31.28% 23.83% 33M |

Consumer Durables

ZCMD | $1.87 28.97% 22.46% 31M |

Commercial Services

RCON | $0.1112 13.01% 21.28% 1.7M |

Distribution Services

INSG | $3.03 25.21% 20.13% 330K |

Electronic Technology

GCTK | $0.8191 22.25% 18.2% 190K |

Manufacturing

WLGS | $0.59 18.0% 17.9% 2.3M |

ASNS | $0.828 21.75% 17.86% 18K |

---

Your saved searches

---